Pfizer : PFE

All Pfizer Articles

1533 Articles

Paul Ausick | Jan 20, 2017 at 11:25 AM EST

5 Worst Performing Dow Stocks of 2017

Even though the new year is barely three weeks old, it's not too soon to take a look at how…

Paul Ausick | Jan 19, 2017 at 4:01 PM EST

Exxon Mobil, Merck Weigh on DJIA Thursday

Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.

Paul Ausick | Jan 17, 2017 at 4:01 PM EST

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

JPMorgan, Goldman Sachs, Pfizer, and UnitedHealth sink DJIA on Tuesday.

Paul Ausick | Jan 12, 2017 at 4:01 PM EST

Disney, Microsoft Lead DJIA Drop Thursday

Disney, Microsoft, Pfizer, and Intel lead DJIA to lower close on Thursday.

Chris Lange | Jan 12, 2017 at 10:50 AM EST

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Jan 11, 2017 at 3:22 PM EST

Wednesday’s Top Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the…

Chris Lange | Jan 5, 2017 at 11:05 AM EST

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a…

Jon C. Ogg | Dec 31, 2016 at 11:14 AM EST

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the…

Jon C. Ogg | Dec 29, 2016 at 10:30 AM EST

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

The Dow has been within 1% of 20,000 for days now. What if the Dow actually manages to hit 22,000…

Douglas A. McIntyre | Dec 29, 2016 at 7:35 AM EST

5 Companies That Will Kill the Dow’s Move to 20,000

Most of the 30 components of the Dow Jones Industrial Average have risen by double-digit percentages this year. But these…

Chris Lange | Dec 28, 2016 at 10:25 AM EST

Short Interest Rises in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest increased in most of…

Douglas A. McIntyre | Dec 22, 2016 at 6:40 AM EST

5 Stocks That Will Keep the Dow Under 20,000

Dow 20,000 does not need all of the index's components to do well. However, these five could be a big…

Paul Ausick | Dec 21, 2016 at 4:01 PM EST

Merck, Pfizer Weigh on DJIA Wednesday

December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think…

Chris Lange | Dec 19, 2016 at 12:20 PM EST

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key…

Paul Ausick | Dec 12, 2016 at 4:01 PM EST

J&J, Wal-Mart Lift Dow Higher Monday

December 12, 2016: Markets opened mixed Monday as traders position themselves for the FOMC meeting announcement due on Wednesday. An…

1 … 46 47 48 49 50 … 103

Pfizer : PFE

All Pfizer Articles

5 Worst Performing Dow Stocks of 2017

Exxon Mobil, Merck Weigh on DJIA Thursday

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

Disney, Microsoft Lead DJIA Drop Thursday

Major Pharma Short Interest Declines Ahead of Trump Comments

Wednesday’s Top Biopharma Movers

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Short Interest Rises in Major Pharma

5 Stocks That Will Keep the Dow Under 20,000

Merck, Pfizer Weigh on DJIA Wednesday

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

J&J, Wal-Mart Lift Dow Higher Monday

3 Dividend Stocks to Buy Before August Ends and Hold for Life

4 Low-Cost ETFs Every Investor Should Own

3 Data Center Stocks Powering the AI Buildout

He Was Laid Off at 63 and Thought Social Security Ruled Out Unemployment. He Was Wrong.

Social Security's 40 Work Credit Rule: Why Some Seniors Don't Qualify for Retirement Benefits

3 REITs Whose Dividends Get Hammered by Taxes, Unless You Own Them in a Roth

These 4 Dividend Stocks Yield Over 7%. Roth Owners Keep Every Penny

Pfizer : PFE

All Pfizer Articles

5 Worst Performing Dow Stocks of 2017

Exxon Mobil, Merck Weigh on DJIA Thursday

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

Disney, Microsoft Lead DJIA Drop Thursday

Major Pharma Short Interest Declines Ahead of Trump Comments

Wednesday’s Top Biopharma Movers

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Short Interest Rises in Major Pharma

5 Stocks That Will Keep the Dow Under 20,000

Merck, Pfizer Weigh on DJIA Wednesday

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

J&J, Wal-Mart Lift Dow Higher Monday

3 Dividend Stocks to Buy Before August Ends and Hold for Life

4 Low-Cost ETFs Every Investor Should Own

3 Data Center Stocks Powering the AI Buildout

Featured Reads

He Was Laid Off at 63 and Thought Social Security Ruled Out Unemployment. He Was Wrong.

Social Security's 40 Work Credit Rule: Why Some Seniors Don't Qualify for Retirement Benefits